Koers Lixte Biotechnology Holdings, Inc.
Aandelen
LIXT
US5393193017
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,26 USD | +1,24% | -5,92% | +38,72% |
23/04 | Lixte Biotechnology dient tot $50 miljoen gemengde Shelf in | MT |
27/03 | Sectorupdate: Gezondheidszorgaandelen stijgen laat in de middag | MT |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 5,29 mln. 4,94 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -6 mln. -5,61 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,68 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 5,35 mln. 5,01 mln. | Nettoliquiditeiten 2023 | 4,2 mln. 3,93 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,28
x | K/w-verhouding 2023 |
-0,88
x | Werknemers | 4 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 68,81% |
1 dag | +1,24% | ||
1 week | -5,92% | ||
Lopende maand | -3,55% | ||
1 maand | +44,57% | ||
3 maanden | +63,82% | ||
6 maanden | +35,27% | ||
Lopend jaar | +38,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 52 | 17-06-22 | |
Director of Finance/CFO | 72 | 12-08-20 | |
Eric Forman
COO | Chief Operating Officer | 44 | 01-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
René Bernards
BRD | Director/Board Member | 72 | 15-06-22 |
Chief Executive Officer | 52 | 17-06-22 | |
Yun Yen
BRD | Director/Board Member | 70 | 04-08-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 3,26 | +1,24% | 4 162 |
25-04-24 | 3,22 | -1,83% | 14 871 |
24-04-24 | 3,28 | +1,86% | 16 082 |
23-04-24 | 3,22 | -3,88% | 40 469 |
22-04-24 | 3,35 | -3,32% | 21 756 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+38,72% | 7,33 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |